Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
July 21, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
June 30, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference
May 19, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, May 19, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
March 24, 2022 16:24 ET
|
Nemaura Medical, Inc
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update
February 14, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches Metabolic Health Program for Employers and Insurers
January 13, 2022 08:30 ET
|
Nemaura Medical, Inc
Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
January 07, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee
December 07, 2021 09:00 ET
|
Nemaura Medical, Inc
Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the...
Nemaura Medical to Present at the Benzinga Global Small Cap Conference
November 30, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
November 15, 2021 09:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...